Showing results (341-350 of 439) with videos related to

Sort By:
Pageof 44
Lancet (London, England)|August 18, 1990
Myeloid neoplasia in children treated for solid tumoursC H Pui, M L Hancock, S C Raimondi, et al.
BMJ Open|July 1, 2022
Feedback of aggregate patient-reported outcomes (PROs) data to clinicians and hospital end users: findings from an Australian codesign workshop processOlivia Francis Ryan, Shaun L Hancock, Violet Marion, et al.
Biomed Research International|January 29, 2016
Temporal Trends and Predictors of Modern Contraceptive Use in Lusaka, Zambia, 2004-2011Nancy L Hancock, Carla J Chibwesha, Marie C D Stoner, et al.
Blood|September 20, 2002
Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemiaElaine Coustan-Smith, Jose Sancho, Michael L Hancock, et al.
Lancet (London, England)|January 22, 1991
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapyG K Rivera, S C Raimondi, M L Hancock, et al.
The Journal of Biological Chemistry|April 14, 2007
Identification of novel Wilms' tumor suppressor gene target genes implicated in kidney developmentHo-Shik Kim, Myoung Shin Kim, Anne L Hancock, et al.
Cancer|December 16, 2004
Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemiaGaston K Rivera, Yinmei Zhou, Michael L Hancock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004)Sridharan Gururangan, William P Petros, Tina Young Poussaint, et al.
Leukemia|February 1, 1992
Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study XC H Pui, J V Simone, M L Hancock, et al.
Oncogene|January 18, 2012
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathwaysA R Dallosso, B Øster, A Greenhough, et al.
Pageof 44